+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Premature Labor (Tocolysis) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768171
  • Report
  • 308 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • AMAG Pharmaceuticals Inc
  • Ferring Holding SA
  • GlaxoSmithKline Plc
  • Hologic Inc
  • Lipocine Inc
  • MORE
The global clinical trial report- “2019 Premature Labor (Tocolysis) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Premature Labor (Tocolysis). It presents in-depth analysis of Premature Labor (Tocolysis) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Premature Labor (Tocolysis).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Premature Labor (Tocolysis) clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Premature Labor (Tocolysis)

The research work is prepared through extensive and continuous research on Premature Labor (Tocolysis) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Premature Labor (Tocolysis) patients are identified
  • The report includes panorama of Premature Labor (Tocolysis) clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Premature Labor (Tocolysis) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • AMAG Pharmaceuticals Inc
  • Ferring Holding SA
  • GlaxoSmithKline Plc
  • Hologic Inc
  • Lipocine Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Premature Labor (Tocolysis) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Premature Labor (Tocolysis) Clinical Trials by Region
2.2.2 Average Enrollment of Premature Labor (Tocolysis) Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Premature Labor (Tocolysis) Treatment, 2019

3. Region wise Premature Labor (Tocolysis) Clinical Trials
3.1 Asia Pacific Premature Labor (Tocolysis) Clinical Trials by Country
3.2 Europe Premature Labor (Tocolysis) Clinical Trials by Country
3.3 North America Premature Labor (Tocolysis) Clinical Trials by Country
3.4 Middle East and Africa Premature Labor (Tocolysis) Clinical Trials by Country
3.5 South and Central America Premature Labor (Tocolysis) Clinical Trials by Country

4. Premature Labor (Tocolysis) Clinical Trial Trends
4.1 Start Year wise Premature Labor (Tocolysis) Clinical Trials
4.2 Phase wise Premature Labor (Tocolysis) Clinical Trials
4.3 Trial Status wise Premature Labor (Tocolysis) Clinical Trials
4.4 Trial Type wise Premature Labor (Tocolysis) Clinical Trials

5. Premature Labor (Tocolysis) Average Enrollment Trends
5.1 Average Enrollment in Premature Labor (Tocolysis) Trials by Year
5.2 Average Enrollment in Premature Labor (Tocolysis) Trials by Phase
5.3 Average Enrollment in Premature Labor (Tocolysis) Trials by Status
5.4 Average Enrollment in Premature Labor (Tocolysis) Trials by Type of Trial

6. Companies Participating in Premature Labor (Tocolysis) Clinical Trials
6.1 Premature Labor (Tocolysis) Trials by Sponsor Type
6.2 Premature Labor (Tocolysis) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Premature Labor (Tocolysis) Trials- Phase 1
7.2 Premature Labor (Tocolysis) Trials- Phase 2
7.3 Premature Labor (Tocolysis) Trials- Phase 3
7.4 Premature Labor (Tocolysis) Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Premature Labor (Tocolysis) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Premature Labor (Tocolysis) Clinical Trials and Enrolment
Figure 5: Europe - Country wise Premature Labor (Tocolysis) Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Premature Labor (Tocolysis) Clinical Trials and Enrolment
Figure 7: North America - Country wise Premature Labor (Tocolysis) Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Premature Labor (Tocolysis) Clinical Trials and Enrolment
Figure 9: Premature Labor (Tocolysis) Clinical Trials by Phase
Figure 10: Premature Labor (Tocolysis) Clinical Trials by Trial Status
Figure 11: Premature Labor (Tocolysis) Clinical Trials by Type
Figure 12: Premature Labor (Tocolysis) Clinical Trials by Sponsor Type
Figure 13: Premature Labor (Tocolysis) Clinical Trials by Leading Sponsors
Figure 14: Premature Labor (Tocolysis) Average Enrollment by Phase
Figure 15: Premature Labor (Tocolysis) Average Enrollment by Trial Status
Figure 16: Premature Labor (Tocolysis) Average Enrollment by Type
Figure 17: Premature Labor (Tocolysis)- Average Enrolment by Type of Sponsors
Figure 18: Premature Labor (Tocolysis)- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Premature Labor (Tocolysis) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Premature Labor (Tocolysis) Clinical Trials and Enrolment
Table 5: Europe - Country wise Premature Labor (Tocolysis) Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Premature Labor (Tocolysis) Clinical Trials and Enrolment
Table 7: North America - Country wise Premature Labor (Tocolysis) Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Premature Labor (Tocolysis) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Premature Labor (Tocolysis) Average Enrollment by Phase
Table 15: Premature Labor (Tocolysis) Average Enrollment by Trial Status
Table 16: Premature Labor (Tocolysis) Average Enrollment by Type
Table 17: Premature Labor (Tocolysis)- Average Enrolment by Type of Sponsors
Table 18: Premature Labor (Tocolysis)- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Laboratories
  • AMAG Pharmaceuticals Inc
  • Emcure Pharmaceuticals Ltd
  • Ferring Holding SA
  • GlaxoSmithKline Plc
  • Hologic Inc
  • Juniper Pharmaceuticals Inc
  • Lipocine Inc
  • ObsEva SA
  • Pharmaceutical Product Development LLC
Note: Product cover images may vary from those shown
Adroll
adroll